• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤衍生的组织因子通过募集髓源性抑制细胞异常激活补体并促进肺肿瘤进展。

Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells.

作者信息

Han Xiao, Zha Haoran, Yang Fei, Guo Bo, Zhu Bo

机构信息

Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.

Department of Pathogenic Biology, Third Military Medical University, Chongqing 400037, China.

出版信息

Int J Mol Sci. 2017 Jan 19;18(1):22. doi: 10.3390/ijms18010022.

DOI:10.3390/ijms18010022
PMID:28106852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5297657/
Abstract

The initiator of extrinsic coagulation, tissue factor (TF), and its non-coagulant isoform alternatively spliced TF (asTF) are closely associated with tumor development. In the tumor microenvironment, the role of TF-induced coagulation in tumor progression remains to be fully elucidated. Using TF-knockdown lung tumor cells, we showed that TF is the dominant component of procoagulant activity but is dispensable in the cellular biology of tumor cells. In a xenograft model, using immunohistochemical analysis and flow cytometry analysis of the tumor microenvironment, we demonstrated that TF-induced fibrin deposition, which is correlated with complement activation and myeloid-derived suppressor cell (MDSC) recruitment, is positively associated with tumor progression. C5aR antagonism blunted the effect of TF on tumor progression and decreased MDSC recruitment. In conclusion, our data suggested that in tumor microenvironment, TF-induced coagulation activated the complement system and subsequently recruited myeloid-derived suppressor cells to promote tumor growth, which brings new insights into the coagulation-induced complement activation within the tumor microenvironment during tumor progression.

摘要

外源性凝血的启动因子组织因子(TF)及其非凝血性异构体可变剪接组织因子(asTF)与肿瘤发展密切相关。在肿瘤微环境中,TF诱导的凝血在肿瘤进展中的作用仍有待充分阐明。利用TF敲低的肺癌细胞,我们发现TF是促凝活性的主要成分,但在肿瘤细胞的细胞生物学中并非必需。在异种移植模型中,通过对肿瘤微环境进行免疫组织化学分析和流式细胞术分析,我们证明TF诱导的纤维蛋白沉积与补体激活和髓源性抑制细胞(MDSC)募集相关,与肿瘤进展呈正相关。C5aR拮抗作用减弱了TF对肿瘤进展的影响,并减少了MDSC募集。总之,我们的数据表明,在肿瘤微环境中,TF诱导的凝血激活补体系统,随后募集髓源性抑制细胞以促进肿瘤生长,这为肿瘤进展过程中肿瘤微环境内凝血诱导的补体激活带来了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/72dd6f2f2ace/ijms-18-00022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/caa29bb60e2d/ijms-18-00022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/91e25da4c996/ijms-18-00022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/4b5a8321d9a1/ijms-18-00022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/468ae1fbf6ef/ijms-18-00022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/72dd6f2f2ace/ijms-18-00022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/caa29bb60e2d/ijms-18-00022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/91e25da4c996/ijms-18-00022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/4b5a8321d9a1/ijms-18-00022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/468ae1fbf6ef/ijms-18-00022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e6/5297657/72dd6f2f2ace/ijms-18-00022-g005.jpg

相似文献

1
Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells.肿瘤衍生的组织因子通过募集髓源性抑制细胞异常激活补体并促进肺肿瘤进展。
Int J Mol Sci. 2017 Jan 19;18(1):22. doi: 10.3390/ijms18010022.
2
A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways.中性粒细胞中一种新型的C5a受体-组织因子相互作用将先天免疫与凝血途径联系起来。
J Immunol. 2006 Oct 1;177(7):4794-802. doi: 10.4049/jimmunol.177.7.4794.
3
Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy.肿瘤微环境中组织因子激活的凝血级联反应对肿瘤的进展至关重要,是治疗的有效靶点。
Cancer Res. 2011 Oct 15;71(20):6492-502. doi: 10.1158/0008-5472.CAN-11-1145. Epub 2011 Aug 31.
4
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.过敏毒素 C5a 为肺癌的进展创造了有利的微环境。
J Immunol. 2012 Nov 1;189(9):4674-83. doi: 10.4049/jimmunol.1201654. Epub 2012 Oct 1.
5
Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro.肿瘤坏死因子-α水平升高可诱导体外培养的猪血管内皮细胞促凝改变。
Xenotransplantation. 2012 May-Jun;19(3):186-95. doi: 10.1111/j.1399-3089.2012.00704.x.
6
Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?微粒相关和肿瘤源性组织因子在血浆中的异质性:其对凝血激活是否重要?
J Thromb Haemost. 2014 Feb;12(2):186-96. doi: 10.1111/jth.12475.
7
Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue Factor.胆固醇晶体通过补体依赖性表达单核细胞组织因子诱导凝血激活。
J Immunol. 2019 Aug 15;203(4):853-863. doi: 10.4049/jimmunol.1900503. Epub 2019 Jul 3.
8
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.癌症中凝血与血管生成的激活:人癌组织中凝血蛋白和血管内皮生长因子的原位免疫组化定位
Am J Pathol. 1998 Feb;152(2):399-411.
9
Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria meningitidis-exposed whole blood.在暴露于脑膜炎奈瑟菌的全血中,通过抑制补体蛋白5可降低微粒相关组织因子活性。
Innate Immun. 2014 Jul;20(5):552-60. doi: 10.1177/1753425913502099. Epub 2013 Sep 19.
10
C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.C5aR、TNF-α 和 FGL2 参与病毒诱导的暴发性肝炎中的凝血和补体激活。
J Hepatol. 2015 Feb;62(2):354-62. doi: 10.1016/j.jhep.2014.08.050. Epub 2014 Sep 6.

引用本文的文献

1
Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer.非小细胞肺癌的肿瘤微环境特征及新型免疫治疗策略
J Natl Cancer Cent. 2022 Oct 20;2(4):243-262. doi: 10.1016/j.jncc.2022.10.002. eCollection 2022 Dec.
2
Interaction between NSCLC Cells, CD8 T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling-New Cues on CAT-VTE.非小细胞肺癌细胞、CD8 T 细胞与免疫检查点抑制剂的相互作用增强了凝血作用,并促进了代谢重编程——CAT-VTE 的新线索。
Cells. 2024 Feb 7;13(4):305. doi: 10.3390/cells13040305.
3
Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling.

本文引用的文献

1
Tissue Factor: A Conventional or Alternative Target in Cancer Therapy.组织因子:癌症治疗中的传统靶点还是替代靶点?
Clin Chem. 2016 Apr;62(4):563-70. doi: 10.1373/clinchem.2015.241521. Epub 2016 Feb 19.
2
Complement System Part I - Molecular Mechanisms of Activation and Regulation.补体系统 第一部分——激活与调节的分子机制
Front Immunol. 2015 Jun 2;6:262. doi: 10.3389/fimmu.2015.00262. eCollection 2015.
3
Levels of Alternatively Spliced Tissue Factor in the Plasma of Patients with Pancreatic Cancer May Help Predict Aggressive Tumor Phenotype.
细胞外纤维蛋白通过整合素β1/PTEN/AKT信号通路促进非小细胞肺癌进展。
Open Life Sci. 2023 Sep 19;18(1):20220716. doi: 10.1515/biol-2022-0716. eCollection 2023.
4
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy.肿瘤内微生物群:在癌症发生、发展和治疗效果中的作用。
Signal Transduct Target Ther. 2023 Jan 16;8(1):35. doi: 10.1038/s41392-022-01304-4.
5
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer.化疗诱导的补体信号转导调节乳腺癌的免疫抑制和转移复发。
Nat Commun. 2022 Oct 2;13(1):5797. doi: 10.1038/s41467-022-33598-x.
6
Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value.肺癌骨转移的预测和预后生物标志物及其治疗价值。
Front Oncol. 2021 Oct 14;11:692788. doi: 10.3389/fonc.2021.692788. eCollection 2021.
7
mTOR Promotes Tissue Factor Expression and Activity in EGFR-Mutant Cancer.mTOR促进EGFR突变型癌症中的组织因子表达和活性。
Front Oncol. 2020 Aug 14;10:1615. doi: 10.3389/fonc.2020.01615. eCollection 2020.
8
Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.髓系细胞阻碍癌症免疫治疗的先天免疫防御机制。
Front Immunol. 2020 Jul 9;11:1395. doi: 10.3389/fimmu.2020.01395. eCollection 2020.
9
Myeloid-derived suppressor cells-new and exciting players in lung cancer.髓系来源的抑制细胞——肺癌中新兴的令人兴奋的角色。
J Hematol Oncol. 2020 Jan 31;13(1):10. doi: 10.1186/s13045-020-0843-1.
10
Urine proteome changes in rats subcutaneously inoculated with approximately ten tumor cells.皮下接种约十个肿瘤细胞的大鼠尿液蛋白质组变化
PeerJ. 2019 Sep 17;7:e7717. doi: 10.7717/peerj.7717. eCollection 2019.
胰腺癌患者血浆中可变剪接组织因子的水平可能有助于预测侵袭性肿瘤表型。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1206-11. doi: 10.1245/s10434-015-4592-2. Epub 2015 May 12.
4
The role of tissue factor isoforms in cancer biology.组织因子异构体在癌症生物学中的作用。
Int J Cancer. 2015 Aug 1;137(3):497-503. doi: 10.1002/ijc.28959. Epub 2014 May 16.
5
Complement anaphylatoxins as immune regulators in cancer.补体过敏毒素作为癌症中的免疫调节因子
Cancer Med. 2014 Aug;3(4):747-58. doi: 10.1002/cam4.241. Epub 2014 Apr 8.
6
Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.肿瘤微环境产生的白细胞介素-17 促进卵巢癌中 CD133+癌症干细胞样细胞的自我更新。
Oncogene. 2015 Jan 8;34(2):165-76. doi: 10.1038/onc.2013.537. Epub 2013 Dec 23.
7
Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells.缺氧诱导的人肺癌细胞中促血管生成组织因子表达的调控。
Oncol Rep. 2013 Jul;30(1):462-70. doi: 10.3892/or.2013.2413. Epub 2013 Apr 22.
8
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.过敏毒素 C5a 为肺癌的进展创造了有利的微环境。
J Immunol. 2012 Nov 1;189(9):4674-83. doi: 10.4049/jimmunol.1201654. Epub 2012 Oct 1.
9
Immuno-PET of tissue factor in pancreatic cancer.胰腺癌组织因子的免疫 PET 显像
J Nucl Med. 2012 Nov;53(11):1748-54. doi: 10.2967/jnumed.112.105460. Epub 2012 Sep 17.
10
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway.凝血酶生成了先前未被识别的 C5 产物,这些产物支持末端补体激活途径。
Blood. 2012 Aug 23;120(8):1717-25. doi: 10.1182/blood-2012-02-412080. Epub 2012 Jul 16.